Propofol

Chemical formula: C₁₂H₁₈O  Molecular mass: 178.271 g/mol  PubChem compound: 4943

Therapeutic indications

Propofol is indicated for:

Maintenance of anaesthesia

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Maintenance of general anaesthesia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Induction of anaesthesia

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Induction of general anesthesia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Sedation for diagnostic and surgical procedures

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Intravenous sedation

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Propofol is contraindicated in the following cases:

Lactation

Lactation

Effects on ability to drive and use machines

Effects on ability to drive and use machines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: PROPOVEN Emulsion for injection/infusion
Summary of Product Characteristics (SPC) 2019: DIPRIVAN Emulsion for injection or infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈